A prolonged release in situ reconfiguring device for the delivery of drugs to solid tumors
The poor response of patients to high-dose chemotherapy commonly associated with the treatment of solid tumors has led to research efforts in the development of implants for the delivery of drug directly to solid tumors. In order to prevent surgical complications associated with the placement of an...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10539/12568 |